PubMed:24749654
Annnotations
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":85},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":86,"end":94},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":95,"end":184},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":185,"end":193},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":194,"end":280},"obj":"Sentence"},{"id":"TextSentencer_T6","span":{"begin":281,"end":378},"obj":"Sentence"},{"id":"TextSentencer_T7","span":{"begin":379,"end":390},"obj":"Sentence"},{"id":"TextSentencer_T8","span":{"begin":391,"end":566},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":85},"obj":"Sentence"},{"id":"T2","span":{"begin":86,"end":94},"obj":"Sentence"},{"id":"T3","span":{"begin":95,"end":184},"obj":"Sentence"},{"id":"T4","span":{"begin":185,"end":193},"obj":"Sentence"},{"id":"T5","span":{"begin":194,"end":280},"obj":"Sentence"},{"id":"T6","span":{"begin":281,"end":378},"obj":"Sentence"},{"id":"T7","span":{"begin":379,"end":390},"obj":"Sentence"},{"id":"T8","span":{"begin":391,"end":566},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.\nPURPOSE: The authors report a case of endophthalmitis after intravitreal injection of ranibizumab.\nMETHODS: After searching for extensive laboratory tests to isolate the etiologic agent Results: The agent was determined as Leuconostoc mesenteroides, gram-positive cocci, vancomycin resistant.\nDISCUSSION: Considerations regarding this bacterium were done by calling attention to its rarity, difficulty of isolation, and action on secondary comorbidities as opportunistic pathogen."}
PubCasesORDO
{"project":"PubCasesORDO","denotations":[{"id":"TI1","span":{"begin":26,"end":41},"obj":"ORDO:199323"},{"id":"AB1","span":{"begin":124,"end":139},"obj":"ORDO:199323"}],"namespaces":[{"prefix":"ORDO","uri":"http://www.orpha.net/ORDO/Orphanet_"}],"text":"Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.\nPURPOSE: The authors report a case of endophthalmitis after intravitreal injection of ranibizumab.\nMETHODS: After searching for extensive laboratory tests to isolate the etiologic agent Results: The agent was determined as Leuconostoc mesenteroides, gram-positive cocci, vancomycin resistant.\nDISCUSSION: Considerations regarding this bacterium were done by calling attention to its rarity, difficulty of isolation, and action on secondary comorbidities as opportunistic pathogen."}
UBERON-AE
{"project":"UBERON-AE","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":214,"end":223},"obj":"http://purl.obolibrary.org/obo/UBERON_2000106"}],"text":"Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.\nPURPOSE: The authors report a case of endophthalmitis after intravitreal injection of ranibizumab.\nMETHODS: After searching for extensive laboratory tests to isolate the etiologic agent Results: The agent was determined as Leuconostoc mesenteroides, gram-positive cocci, vancomycin resistant.\nDISCUSSION: Considerations regarding this bacterium were done by calling attention to its rarity, difficulty of isolation, and action on secondary comorbidities as opportunistic pathogen."}
performance-test
{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":214,"end":223},"obj":"http://purl.obolibrary.org/obo/UBERON_2000106"}],"text":"Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.\nPURPOSE: The authors report a case of endophthalmitis after intravitreal injection of ranibizumab.\nMETHODS: After searching for extensive laboratory tests to isolate the etiologic agent Results: The agent was determined as Leuconostoc mesenteroides, gram-positive cocci, vancomycin resistant.\nDISCUSSION: Considerations regarding this bacterium were done by calling attention to its rarity, difficulty of isolation, and action on secondary comorbidities as opportunistic pathogen."}